Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets.
von Tempelhoff
G F
GF
Heilmann
L
L
Spanuth
E
E
Kunzmann
E
E
Hommel
G
G
D017152:Antibodies, Antiphospholipid / Q000097:blood*; D001778:Blood Coagulation Disorders / Q000453:epidemiology*; D004461:Eclampsia / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D005165:Factor V / Q000235:genetics; D005260:Female; D017359:HELLP Syndrome / Q000097:blood / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D017354:Point Mutation; D011225:Pre-Eclampsia / Q000097:blood / Q000453:epidemiology / Q000209:etiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000209:etiology; D019851:Thrombophilia / Q000097:blood / Q000150:complications*
D017152:Antibodies, Antiphospholipid; C095381:factor V Leiden; D005165:Factor V